Trial of Upadacitinib or Abatacept in Rheumatoid Arthritis

Original Article

A. Rubbert-Roth, J. Enejosa, A.L. Pangan, B. Haraoui, M. Rischmueller, N. Khan, Y. Zhang, N. Martin, and R.M. Xavier

N Engl J Med 2020;383:1511-1521

Course summary
Available credit: 
  • 1.00 AMA PRA Category 1 Credit™
  • 1.00 Participation
Course opens: 
10/14/2020
Course expires: 
10/15/2022

Available Credit

  • 1.00 AMA PRA Category 1 Credit™
  • 1.00 Participation

Course closed

This course closed on Saturday, October 15, 2022 - 11:59pm.